Centro Rosarista de Salud Mental - CeRSaMe

Keyphrases

1. COVID-19 Pandemic 100%
2. Schizophrenia 68%
3. COVID-19 67%
4. Psychiatrists 54%
5. First-episode Psychosis 52%
6. Colombia 42%
7. Early Career Psychiatrists 38%
8. Mental Health 35%
9. Schizophrenic Patients 34%
10. Healthy Controls 30%
11. Mental Health Care 30%
12. COVID-19 Related 27%
13. Schizophrenia Spectrum Disorders 27%
14. Colombians 27%
15. Mental Health Problems 26%
16. Treatment-resistant Depression 26%
17. Colombian Patients 26%
18. Healthcare 25%
19. Healthcare Workers 25%
20. Patients with Schizophrenia 24%
21. Psychosis 22%
22. Health Personnel 20%
23. Depressive Symptoms 19%
24. Mental Hospital 18%
25. 2-year Follow-up 18%
26. Expressed Emotion 17%
27. Assistive Technology 17%
28. Telepsychiatry 17%
29. Age-related Illnesses 17%
30. Social Cognition 17%
31. Neurovascular Unit 17%
32. Early Course 17%
33. Delphi Panel 17%
34. Adverse Drug Event Reporting 17%
35. Absolute Neutrophil Count 17%
36. Treatment Consensus 17%
37. Clozapine Treatment 17%
38. Duration of Untreated Psychosis 17%
39. Vulnerability 16%
40. Bogota Colombia 15%
41. COVID-19 Infection 15%
42. Major Depressive Disorder 15%
43. Macular 15%
44. World Health Organization 15%
45. Prodromal Symptoms 14%
46. Crisis Time 13%
47. Negative Symptoms 13%
48. Retinal Structure 13%
49. High Prevalence 13%
50. Prosody 13%
51. Telemental Health 13%
52. Persons with Mental Illness 13%
53. Private Practitioners 11%
54. Mental Health Services 11%
55. Psychometric Properties 11%
56. International Research 11%
57. Psychotic Symptoms 11%
58. Clozapine 11%
59. Retina 10%
60. Antipsychotics 10%
61. First Year 10%
62. Narrative Review 10%
63. Bipolar Disorder 10%
64. Neurocognitive Function 10%
65. Hospitalization 10%
66. Anxiety Symptoms 10%
67. Tobacco Use 10%
68. Risk Factors 10%
69. Latin America (LATAM) 10%
70. Clinical Outcomes 10%
71. Group of People 10%
72. Psychotic Disorders 9%
73. Randomized Controlled Trial 8%
74. Sign Language Interpreting 8%
75. Health Communication 8%
76. Deaf children 8%
77. Clozapine-resistant Schizophrenia 8%
78. Peer Research 8%
79. Learning Support 8%
80. Peer Support 8%
81. Peer Learning 8%
82. Paternal Absence 8%
83. Childhood Experience 8%
84. Extraperitoneal Space 8%
85. Acoustic Analysis 8%
86. Suicidio 8%
87. Mental Health Workforce 8%
88. Prospective Observational Study 8%
89. Treatment Impact 8%
90. Mental Health Patients 8%
91. Indentity 8%
92. Artificial Intelligence Algorithm 8%
93. Complicated Grief 8%
94. Neutrophil-lymphocyte Ratio 8%
95. Grief Experiences 8%
96. Active Patient 8%
97. Economically Active 8%
98. Retinal Abnormalities 8%
99. Peripapillary 8%
100. Peripapillary Retinal Nerve Fiber Layer (pRNFL) 8%